August 3, 2017 / 1:25 PM / 2 years ago

BRIEF-Catalyst Biosciences posts Q2 loss of $2.53 per share

Aug 3 (Reuters) - Catalyst Biosciences Inc

* Catalyst biosciences reports second quarter 2017 financial results and provides subcutaneous (sq) hemophilia program update

* Q2 loss per share $2.53

* Catalyst biosciences inc - ‍cash, cash equivalents and short-term investments as of june 30, 2017 were $32.4 million​

* Catalyst biosciences inc - believes existing capital resources will be sufficient to meet projected operating requirements for at least next 12 months​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below